Conference Proceedings
Development of a clinically accessible, circulating prognostic lipid biomarker panel in men with mCRPC to guide potential metabolic intervention
T Scheinberg, M Fitzpatrick, H-M Lin, AA Azad, P Bonnitcha, AG Davies, G Heller, K Huynh, B Mak, K Mahon, P Meikle, D Sullivan, LG Horvath
ANNALS OF ONCOLOGY | ELSEVIER | Published : 2022
Grants
Awarded by National Health and Medical Research Council of Australia
Awarded by Cancer Institute New South Wales
Awarded by Prostate Cancer Foundation of Australia
Awarded by Cancer Council New South Wales
Awarded by Victorian Cancer Agency Clinical Research Fellowship
Funding Acknowledgements
National Health and Medical Research Council of Australia (GNT1196225 to LGH, GNT1098647 to AAA); Cancer Institute New South Wales (10/TPG/1-04, 2018/TPG001); Australian Prostate Cancer Research Centre-New South Wales; Australian Department of Health and Aging; the Movember Foundation and the Prostate Cancer Foundation of Australia (Revolutionary Team Award MRTA3); Cancer Council New South Wales (PG 10-01); The Victorian Government's Operational Infrastructure Support Program; Australian Government Research Training Program (RTP) Scholarship and University of Sydney Merit Award to BM; Australian Government Research Training Program (RTP) Scholarship and Sydney Catalyst Research Top-up Award to TS; Victorian Cancer Agency Clinical Research Fellowship (CRF14009) and Astellas Investigator-Initiated Grant to AAA; ANZUP Noel Castan Fellowship to HML; Twin Towns Services Community Foundation to LGH.